ISDS Case Map
health
In a letter to Congress, the groups demand that the pact’s giveaways to Big Pharma that would keep medicines unaffordable be removed before the pact is sent to Congress.
NAFTA 2.0 would effectively tie the US Congress’ hands in the struggle against rising drug prices.
The Intellectual Property Chapter of the revised NAFTA, rebranded by the Trump Administration USMCA, includes provisions that threaten to undermine critical efforts towards affordable health care and medicine.
Proposals from Japan and South Korea would require patent law changes in several RCEP countries, including Indonesia.
Multinational corporations are suing countries for using generic versions of life saving medicines.
We condemn the secretly negotiated Regional Comprehensive Economic Partnership (RCEP) which will erode people’s sovereignty and undermine health equity.
The German Supreme Court dismissed the original arbitration decision against Slovakia concerning the ban on health-insurance companies’ profits.
Canada’s negotiators extended data protection on biologics without knowing impact on prices.
Treasury minister was speaking on the same day the Cato Institute called for softer environmental rules and NHS competition.
Japan is planning to accept a greater number of caregivers from three Southeastern Asian countries having bilateral free trade agreements with Tokyo as part of efforts to address a labour shortage in the country.
